Design and Synthesis of Tricyclic JAK3 Inhibitors with Picomolar Affinities as Novel Molecular Probes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design and Synthesis of Tricyclic JAK3 Inhibitors with Picomolar Affinities as Novel Molecular Probes
Authors
Keywords
-
Journal
ChemMedChem
Volume 9, Issue 2, Pages 277-281
Publisher
Wiley
Online
2014-01-09
DOI
10.1002/cmdc.201300520
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012
- (2013) Brian W Dymock et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2
- (2013) Mark Zak et al. JOURNAL OF MEDICINAL CHEMISTRY
- 1-[(3RS,4RS)-1-Benzyl-4-methylpiperidin-3-yl]-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine hemihydrate
- (2012) Ellen Pfaffenrot et al. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
- Tofacitinib for the treatment of rheumatoid arthritis
- (2012) Cristiano AF Zerbini et al. Expert Review of Clinical Immunology
- Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2
- (2012) Mark Zak et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Frozen Analogue Approach to Aminopyridinylimidazoles Leading to Novel and Promising p38 MAP Kinase Inhibitors
- (2012) Roland Selig et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors
- (2012) Janusz J. Kulagowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- A public-private partnership to unlock the untargeted kinome
- (2012) Stefan Knapp et al. Nature Chemical Biology
- Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
- (2011) Keith W. Rickert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oxetanes in Drug Discovery: Structural and Synthetic Insights
- (2010) Georg Wuitschik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection
- (2010) Mark E. Flanagan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6
- (2010) Jill E. Chrencik et al. JOURNAL OF MOLECULAR BIOLOGY
- JAK3: A two-faced player in hematological disorders
- (2009) Melanie G. Cornejo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
- (2009) Neal K. Williams et al. JOURNAL OF MOLECULAR BIOLOGY
- Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)
- (2008) Jian-kang Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now